Literature DB >> 1995356

Limited resection for Stage I lung cancer.

U Pastorino1, M Valente, V Bedini, M Infante, L Tavecchio, G Ravasi.   

Abstract

We have reviewed our experience of limited resections for Stage I lung cancer for the years 1971-88. Sixty-one cases of sublobar resection (wedge or segmental) were compared with 411 lobar resections (lobectomies or bilobectomies), performed over the same period. Operative mortality was 0% in the limited resection group and 3% (12/411) in the control group. Cancer recurrence was detected respectively in 36% and 38% of patients, and actuarial survival at 5 years was 55% versus 49% overall. Sublobar resection had a slightly better outcome than lobar resection in pathological T1 (5-year survival of 73% vs 55%) but a worse outcome in pT2 (35% vs 46%); however, none of the differences was statistically significant. In 28 patients with pre-existing cardiac or pulmonary co-morbidity, limited resection yielded the same 5-year survival as lobectomy (53% vs 51%) with no peri-operative deaths (0 vs 5%). Although derived from a retrospective analysis, these data offer a further confirmation that limited resection combined with adequate nodal staging is a reliable and effective technique for early stage lung cancer management.

Entities:  

Mesh:

Year:  1991        PMID: 1995356

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

1.  Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Authors:  Rodney J Landreneau; Daniel P Normolle; Neil A Christie; Omar Awais; Joseph J Wizorek; Ghulam Abbas; Arjun Pennathur; Manisha Shende; Benny Weksler; James D Luketich; Matthew J Schuchert
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

2.  Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication.

Authors:  Nobumasa Takahashi; Noriyoshi Sawabata; Masafumi Kawamura; Takashi Ohtsuka; Hirotoshi Horio; Hirozou Sakaguchi; Mitsuo Nakayama; Katsuo Yoshiya; Masayuki Chida; Eishin Hoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-27

Review 3.  A decade of advances in treatment of early-stage lung cancer.

Authors:  Luca Paoletti; Nicholas J Pastis; Chadrick E Denlinger; Gerard A Silvestri
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

Review 4.  Surgical Management of Lung Cancer: History, Evolution, and Modern Advances.

Authors:  Abbas E Abbas
Journal:  Curr Oncol Rep       Date:  2018-11-13       Impact factor: 5.075

Review 5.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

Review 6.  Sublobar resection for early-stage lung cancer.

Authors:  Hiroyuki Sakurai; Hisao Asamura
Journal:  Transl Lung Cancer Res       Date:  2014-06

7.  Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009.

Authors:  Anna L McGuire; Wilma M Hopman; Dimitri Petsikas; Ken Reid
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

8.  The safety and feasibility of thoracoscopic uncommon pulmonary segmentectomy.

Authors:  Hitoshi Igai; Mitsuhiro Kamiyoshihara; Ryohei Yoshikawa; Fumi Osawa; Tomohiro Yazawa
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

9.  Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue.

Authors:  Shin-Kwang Kang; Jin San Bok; Hyun Jin Cho; Min-Woong Kang
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

10.  Limited resection in clinical stage I non-small cell lung cancer patients aged 75 years old or more: a meta-analysis.

Authors:  Zhenrong Zhang; Hongxiang Feng; Fei Xiao; Deruo Liu
Journal:  Ann Transl Med       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.